Cargando…

Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer

The number of patients with lung cancer is difficultly diagnosed in the early stage. The purpose of the study was to investigate the effects of CT- and ultrasound-guided percutaneous transthoracic needle biopsy combined with serum CA125 and CEA on the diagnosis of lung cancer. 120 patients with susp...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaoyin, Huang, Jinbiao, Wang, Minke, Bi, Weixu, Fan, Tianbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759864/
https://www.ncbi.nlm.nih.gov/pubmed/35035813
http://dx.doi.org/10.1155/2022/2289432
_version_ 1784633195527929856
author Wang, Zhaoyin
Huang, Jinbiao
Wang, Minke
Bi, Weixu
Fan, Tianbing
author_facet Wang, Zhaoyin
Huang, Jinbiao
Wang, Minke
Bi, Weixu
Fan, Tianbing
author_sort Wang, Zhaoyin
collection PubMed
description The number of patients with lung cancer is difficultly diagnosed in the early stage. The purpose of the study was to investigate the effects of CT- and ultrasound-guided percutaneous transthoracic needle biopsy combined with serum CA125 and CEA on the diagnosis of lung cancer. 120 patients with suspected lung cancer admitted to our hospital from January 2019 to January 2020 were selected and divided into an ultrasound group (n = 60) and CT group (n = 60), according to different percutaneous transthoracic needle biopsy modalities. All patients received serum tumor markers detection, so as to compare the CT- and ultrasound-guided percutaneous transthoracic needle biopsy results and pathology results, levels of serum tumor markers among all patients and the patients with different lung cancer types, and diagnostic efficacy of tumor markers, as well as complication rate (CR) in patients. The sensitivity and specificity of ultrasound-guided percutaneous transthoracic needle biopsy were 0.880 and 0.800, respectively, while those of CT-guided percutaneous transthoracic needle biopsy were 0.909 and 0.625, respectively; the CA125 and CEA levels in the lung cancer group were higher than those in the benign group (P < 0.001); the CA125 and CEA levels of the patients with adenocarcinoma were higher than those with squamous carcinoma, and the CEA levels of the patients with small-cell carcinoma were lower than those with adenocarcinoma (P < 0.05); the sensitivity, specificity, and Youden indexes of CA125 were 0.638, 0.833, and 0.471, respectively, while those of CEA were 0.766, 0.778, and 0.544, respectively; there were no significant differences in CR between the two groups (P > 0.05). CT- and ultrasound-guided percutaneous transthoracic needle biopsy is a safe and feasible diagnostic modality for lung cancer, and its combination with serum CA125 and CEA can significantly improve the accuracy of the detection results, which is worthy of promotion and application in clinical practice.
format Online
Article
Text
id pubmed-8759864
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-87598642022-01-15 Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer Wang, Zhaoyin Huang, Jinbiao Wang, Minke Bi, Weixu Fan, Tianbing J Healthc Eng Research Article The number of patients with lung cancer is difficultly diagnosed in the early stage. The purpose of the study was to investigate the effects of CT- and ultrasound-guided percutaneous transthoracic needle biopsy combined with serum CA125 and CEA on the diagnosis of lung cancer. 120 patients with suspected lung cancer admitted to our hospital from January 2019 to January 2020 were selected and divided into an ultrasound group (n = 60) and CT group (n = 60), according to different percutaneous transthoracic needle biopsy modalities. All patients received serum tumor markers detection, so as to compare the CT- and ultrasound-guided percutaneous transthoracic needle biopsy results and pathology results, levels of serum tumor markers among all patients and the patients with different lung cancer types, and diagnostic efficacy of tumor markers, as well as complication rate (CR) in patients. The sensitivity and specificity of ultrasound-guided percutaneous transthoracic needle biopsy were 0.880 and 0.800, respectively, while those of CT-guided percutaneous transthoracic needle biopsy were 0.909 and 0.625, respectively; the CA125 and CEA levels in the lung cancer group were higher than those in the benign group (P < 0.001); the CA125 and CEA levels of the patients with adenocarcinoma were higher than those with squamous carcinoma, and the CEA levels of the patients with small-cell carcinoma were lower than those with adenocarcinoma (P < 0.05); the sensitivity, specificity, and Youden indexes of CA125 were 0.638, 0.833, and 0.471, respectively, while those of CEA were 0.766, 0.778, and 0.544, respectively; there were no significant differences in CR between the two groups (P > 0.05). CT- and ultrasound-guided percutaneous transthoracic needle biopsy is a safe and feasible diagnostic modality for lung cancer, and its combination with serum CA125 and CEA can significantly improve the accuracy of the detection results, which is worthy of promotion and application in clinical practice. Hindawi 2022-01-07 /pmc/articles/PMC8759864/ /pubmed/35035813 http://dx.doi.org/10.1155/2022/2289432 Text en Copyright © 2022 Zhaoyin Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Zhaoyin
Huang, Jinbiao
Wang, Minke
Bi, Weixu
Fan, Tianbing
Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title_full Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title_fullStr Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title_full_unstemmed Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title_short Analysis on the Effects of CT- and Ultrasound-Guided Percutaneous Transthoracic Needle Biopsy Combined with Serum CA125 and CEA on the Diagnosis of Lung Cancer
title_sort analysis on the effects of ct- and ultrasound-guided percutaneous transthoracic needle biopsy combined with serum ca125 and cea on the diagnosis of lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759864/
https://www.ncbi.nlm.nih.gov/pubmed/35035813
http://dx.doi.org/10.1155/2022/2289432
work_keys_str_mv AT wangzhaoyin analysisontheeffectsofctandultrasoundguidedpercutaneoustransthoracicneedlebiopsycombinedwithserumca125andceaonthediagnosisoflungcancer
AT huangjinbiao analysisontheeffectsofctandultrasoundguidedpercutaneoustransthoracicneedlebiopsycombinedwithserumca125andceaonthediagnosisoflungcancer
AT wangminke analysisontheeffectsofctandultrasoundguidedpercutaneoustransthoracicneedlebiopsycombinedwithserumca125andceaonthediagnosisoflungcancer
AT biweixu analysisontheeffectsofctandultrasoundguidedpercutaneoustransthoracicneedlebiopsycombinedwithserumca125andceaonthediagnosisoflungcancer
AT fantianbing analysisontheeffectsofctandultrasoundguidedpercutaneoustransthoracicneedlebiopsycombinedwithserumca125andceaonthediagnosisoflungcancer